Want help reviewing this study?
Study ID: NCT02097706. We help you review the study, but cannot decide medical eligibility.
RecruitingNCT02097706
NMDA receptor antagonist (active drug) for Borderline Personality Disorder
The registry lists this study as recruiting. Study locations are listed in Australia. Confirm recruitment at each site. It is testing NMDA receptor antagonist (active drug) for Borderline Personality Disorder.
Personality disorders, Borderline personalityDrugFrom 18 Years to 65 Years
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJanuary 2015
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 150
- Sponsor
- The Alfred
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Australia
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02097706
- Official title
- A Randomised Double-blind Placebo Controlled Investigation of the Efficacy of a Novel Drug as an Adjunct in Patients With Borderline Personality Disorder
Recruitment & locations
RecruitingMelbourne, Australia
Compensation and expense reimbursement have not been verified for this summary.
Registry details
Registry conditions (original wording)
Borderline Personality Disorder
Questions about this study
Who is behind this study?
The study sponsor is The Alfred.
Does this study involve medication?
Yes. The study involves medication, including NMDA receptor antagonist (active drug).
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
RecruitingACTRN12617001317381
Estrogen for Borderline Personality Disorder/Complex PTSD
This study is recruiting. It focuses on personality disorders and currently lists participation information in Australia.
RecruitingACTRN12618001687280
A Dismantling Study of Dialectical Behaviour Therapy (DBT) Skills: Investigating the Effectiveness of Distress Tolerance, Emotion Regulation, and Interpersonal Effectiveness Skills Groups
The registry lists this study as recruiting. Study locations are listed in Australia. Confirm recruitment at each site. It focuses on Personality disorders.
RecruitingACTRN12624000195550
A hybrid controlled feasibility study of a self-management intervention “My Personal REcovery Plan” (MyPREP) for people with long term mental health conditions: The MyPREP study
The registry lists this study as recruiting. Study locations are listed in Australia. Confirm recruitment at each site. It focuses on Personality disorders.